$1.180
+0.010 (+0.85%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
RGNT 相似图表分析预测
Alphio's RGNT stock price prediction model matches the current Regentis Biomaterials Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.19 (+0.51%). The 1-week path is $1.14 (-3.31%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Regentis Biomaterials Ltd 股票吗？
Regentis Biomaterials Ltd is not a good buy right now due to its extremely low RSI of 26.439, indicating oversold conditions, and a staggering year-to-date decline of 82.49%.
RGNT 股价于 Friday 收于 $1.18，此前上涨 +0.85%
Regentis Biomaterials Ltd (RGNT) last closed at $1.1799999, gaining +0.85%. These facts feed the 1-day and 1-week RGNT price prediction above.
预测驱动因素
Regentis Biomaterials Ltd（RGNT）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 RGNT 最接近的股票，按相似度排序。
RGNT 季节性分析
Historically the probability of a positive November return for RGNT is 0.00%. January offers the highest probability of a positive month at 45.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
相关文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。